Coronary artery bypass grafting (CABG) vs. percutaneous coronary intervention (PCI) in the treatment of multivessel coronary disease: quo vadis? —a review of the evidences on coronary artery disease
Why the study?
Does coronary artery bypass grafting (CABG) improve survival and reduce major cardiovascular events compared to percutaneous coronary intervention (PCI) with drug-eluting stents in patients with multivessel coronary disease?
Population
Patients with multivessel ischemic coronary artery disease
Comparison
Coronary artery bypass grafting (CABG) vs Percutaneous coronary intervention with…
Design
Review
Follow-up
short and long-term
Authors
Discussion
Loading...
Member takes
Implication
Supports CABG over PCI in multivessel CAD; reinforces RCT evidence for lower mortality and repeat revascularization.
Structured PICO
Does coronary artery bypass grafting (CABG) improve survival and reduce major cardiovascular events compared to percutaneous coronary intervention (PCI) with drug-eluting stents in patients with multivessel coronary disease?
P
Population
Patients with multivessel ischemic coronary artery disease
I
Intervention
Coronary artery bypass grafting (CABG)
C
Comparator
Percutaneous coronary intervention (PCI) with drug-eluting stents
O
Outcome
Survival, major cardiovascular events (specifically myocardial infarction or stroke), and repeat revascularizationhard clinical
This review reinforces that CABG offers superior survival and lower rates of major cardiovascular events and repeat revascularization compared to PCI with drug-eluting stents in patients with multivessel coronary artery disease.
Cite This Study
Spadaccio et al. (2018) studied this question.